Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9PAQ

Crystal Structure of the Klebsiella pneumoniae LpxH/E2-1 Complex

This is a non-PDB format compatible entry.
Summary for 9PAQ
Entry DOI10.2210/pdb9paq/pdb
DescriptorUDP-2,3-diacylglucosamine hydrolase, N-(4-{2-[4-(3,5-dichlorophenyl)piperazin-1-yl]-2-oxoethyl}phenyl)-2-[(methanesulfonyl)(methyl)amino]benzamide, DI(HYDROXYETHYL)ETHER, ... (6 entities in total)
Functional Keywordslipid a, lpxh, gram-negative bacteria, antibiotic
Biological sourceKlebsiella pneumoniae
Total number of polymer chains1
Total formula weight30712.54
Authors
Cochrane, C.S.,Zhou, P. (deposition date: 2025-06-25, release date: 2026-05-06)
Primary citationZhang, G.,Cochrane, C.S.,Yang, B.,Zhao, J.,Jin, H.,Wu, S.,Zhou, P.,Xia, J.
Structure-Based Discovery of a New LpxH-Targeted Chemotype with Activity against Klebsiella pneumoniae.
J.Med.Chem., 69:6691-6705, 2026
Cited by
PubMed Abstract: Gram-negative pathogens are difficult to treat because their outer membrane, enriched with lipid A-anchored lipopolysaccharide, serves as a protective barrier to many antibiotics. LpxH, an essential dimanganese hydrolase in lipid A biosynthesis, represents a promising antimicrobial target, but its distinct L-shaped binding pocket has limited inhibitor development, with only the sulfonylpiperazine chemotype reported to date. To broaden the chemical space, we developed a multistage virtual screening workflow combining HipHop-based pharmacophore modeling, ROCS-based query matching, and FRED docking. This pipeline identified , an acetylpiperazine-containing compound, as a moderate LpxH (LpxH) inhibitor. Substructure searching and optimization yielded compound , a potent inhibitor (IC: 0.17 μM) with moderate antibacterial activity (MIC: 5.3 μg/mL). The crystal structure of the LpxH-compound complex revealed its binding mode, validating virtual screening analysis. These studies establish acetylpiperazine derivatives as a new class of LpxH inhibitors and provide a foundation for future antibiotic development.
PubMed: 41784176
DOI: 10.1021/acs.jmedchem.5c02939
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

253795

PDB entries from 2026-05-20

PDB statisticsPDBj update infoContact PDBjnumon